Product Information
NUVIGIL 200 MG TABLET is a brand product labeled by Cephalon, LLC, priced at $35.0624 per EA under NDC 63459022030. Its NADAC has been published 285 times since Jul 23, 2014.
FDA first approved this application on Jun 15, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Cephalon, LLCNDC
63459022030
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
11/19/2025
Active Ingredients
ARMODAFINILApproval Type
New Drug (NDA)
FDA Application
NDA021875FDA Approved
6/15/2007
TE Code
AB
On Market Since
2/20/2014
Price Statistics
The NADAC for NUVIGIL 200 MG TABLET has been published 285 times since Jul 23, 2014, and over the history we have for it it has risen 115.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $35.0624 per EA |
|---|---|
| All-time high | $35.0624 (Sep 30, 2026) |
| All-time low | $16.1946 (Aug 20, 2014) |
| 52-week high | $35.0624 |
| 52-week low | $34.8872 |
| Median price | $21.1891 |
| Average price | $24.3909 |
| Largest weekly change | +64.2% (Dec 18, 2024) |
| Weeks tracked | 285 |
| Tracking since | Jul 23, 2014 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cephalon, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Armodafinil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NUVIGIL 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NUVIGIL 200 MG TABLET, manufactured by Cephalon, LLC, is $35.0624 per EA (NDC 63459022030), effective Sep 30, 2026.
How has the price of NUVIGIL 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for NUVIGIL 200 MG TABLET has risen 115.3%. It has been tracked across 285 weekly CMS publications since Jul 23, 2014.
What are the highest and lowest recorded NADAC prices for NUVIGIL 200 MG TABLET?
Since Jul 23, 2014, the NADAC for NUVIGIL 200 MG TABLET has ranged from a low of $16.1946 (Aug 20, 2014) to a high of $35.0624 (Sep 30, 2026), with a median of $21.1891 per EA.
Are there cheaper alternatives to NUVIGIL 200 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ARMODAFINIL 200 MG TABLET, is $0.8028 per EA — about 98% below NUVIGIL 200 MG TABLET.
Who manufactures NUVIGIL 200 MG TABLET?
NUVIGIL 200 MG TABLET (NDC 63459022030) is labeled by Cephalon, LLC, and CMS classifies it as a brand product.